Rheumatology Academy

Investigating the Impact of COVID-19 on Patients with Rheumatic Diseases

Investigating the Impact of COVID-19 on Patients with Rheumatic Diseases
RestartResume

Get a quick snapshot of one of the presentations featured at the 2021 American College of Rheumatology Convergence.

  • Overview

    Which of our patients with rheumatic diseases are at higher risk for severe outcomes from COVID-19? That’s the exact question Dr. Jinoos Yazdany, Chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital, addresses in her presentation at the 2021 American College of Rheumatology (ACR) Convergence.

Facebook Comments

Register

We’re glad to see you’re enjoying Rheumatology Academy…
but how about a more personalized experience?

Register for free